Safety evaluation of turmeric polysaccharide extract: Assessment of mutagenicity and acute oral toxicity

29Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Curcuma longa Linn. (Zingiberaceae) commonly known as turmeric has long been used for centuries as a spice and household remedy. The present study was carried out to assess the possible mutagenic potential and acute oral toxicity of polysaccharide extract of turmeric rhizome (NR-INF-02) using standard tests. The standard battery of in vitro genotoxicity tests, bacterial reverse mutation test (BRMT), chromosome aberration (CA), and micronucleus (MN) tests were employed to assess the possible mutagenic activity of NR-INF-02 (Turmacin). The results showed no mutagenic effect with NR-INF-02 up to a dose of 5000 μg/mL in BRMT. The results on CA and MN tests revealed the non clastogenic activity of NR-INF-02 in a dose range of 250.36 to 2500 μg/mL with and without metabolic activation (S9). In acute oral toxicity study, NR-INF-02 was found to be safe up to 5 g/kg body weight in Wistar rats. Overall, results indicated that polysaccharide extract of C. longa was found to be genotoxically safe and also exhibited maximum tolerable dose of more than 5 g/kg rat body weight. © 2013 Chandrasekaran Chinampudur Velusami et al.

Cite

CITATION STYLE

APA

Velusami, C. C., Boddapati, S. R., Hongasandra Srinivasa, S., Richard, E. J., Joseph, J. A., Balasubramanian, M., & Agarwal, A. (2013). Safety evaluation of turmeric polysaccharide extract: Assessment of mutagenicity and acute oral toxicity. BioMed Research International, 2013. https://doi.org/10.1155/2013/158348

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free